(Q45280874)

11 December 2017

Survival analysis in familial ovarian cancer, a case control study (English)

1 reference

11 December 2017

1 reference

5

van Diest PJ

1 reference

11 December 2017

Zweemer RP

1

1 reference

11 December 2017

Verheijen RH

2

1 reference

11 December 2017

Coebergh JW

3

1 reference

11 December 2017

Jacobs IJ

4

1 reference

11 December 2017

Gille JJ

6

1 reference

11 December 2017

Skates S

7

1 reference

11 December 2017

Menko FH

8

1 reference

11 December 2017

Ten Kate LP

9

1 reference

11 December 2017

Kenemans P

10

1 reference

11 December 2017

1 October 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

11 December 2017

1 reference

11 December 2017

98

1 reference

11 December 2017

2

1 reference

11 December 2017

219-223

1 reference

Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the Netherlands

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

An evaluation of prognostic factors in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Quantification of p53 in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

BRCA2 mutations in primary breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Clinical and genetic evaluation of thirty ovarian cancer families.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Histology of BRCA1-associated ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900318-9

7 January 2021

10.1016/S0301-2115(01)00318-9

Identifiers

DOI

1 reference

11 December 2017

1 reference